• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在对侧眼转变为新生血管性年龄相关性黄斑变性时视觉功能生活质量测量的变化。

Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.

作者信息

Paulus Yannis M, Jefferys Joan L, Hawkins Barbara S, Scott Adrienne W

机构信息

Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.

Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.

出版信息

Qual Life Res. 2017 Aug;26(8):2139-2151. doi: 10.1007/s11136-017-1547-z. Epub 2017 Mar 29.

DOI:10.1007/s11136-017-1547-z
PMID:28357680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5511091/
Abstract

PURPOSE

To determine changes in quality of life measures when choroidal neovascularization (CNV) developed in the second eye of patients with initially unilateral neovascular age-related macular degeneration (AMD).

METHODS

We analyzed responses to the 39-item National Eye Institute Visual Function Questionnaire (NEI-VFQ), 36-item Short Form Health Survey (SF-36), and Hospital Anxiety and Depression Scale (HADS) at baseline, and prior to and following second eye CNV diagnosis in 92 participants enrolled in two Submacular Surgery Trials. Paired t-tests for sample sizes over 30 and Wilcoxon signed-rank tests for sample sizes <30 were performed to compare scores.

RESULTS

CNV development resulted in statistically and clinically significant changes in responses to 20 of 39 NEI-VFQ items, indicating visual function decline during a mean interval of 25 months. Little difference was noted between baseline scores and prior to CNV diagnosis, which averaged 8.9 months duration. Subscales demonstrated a statistically significant decline in general vision, near activities, distance activities, social functioning, role difficulties, dependency, and driving. There were minimal changes in the HADS and SF-36 scales.

CONCLUSION

CNV development in the second eye had a dramatic effect on visual functioning based on patient responses to the NEI-VFQ questionnaire. Our investigation is believed to be the first study using data collected prospectively to demonstrate vision-related quality of life changes that resulted from development of CNV in AMD patients.

摘要

目的

确定初发为单侧新生血管性年龄相关性黄斑变性(AMD)患者的对侧眼发生脉络膜新生血管(CNV)时生活质量指标的变化情况。

方法

我们分析了92名参与两项黄斑下手术试验的受试者在基线时、对侧眼CNV诊断之前及之后对39项美国国立眼科研究所视觉功能问卷(NEI-VFQ)、36项简明健康调查问卷(SF-36)以及医院焦虑抑郁量表(HADS)的回答。对样本量超过30的采用配对t检验,对样本量小于30的采用Wilcoxon符号秩检验来比较得分。

结果

CNV的发生导致39项NEI-VFQ条目中的20项在统计学和临床上出现显著变化,表明在平均25个月的时间间隔内视觉功能下降。在基线得分与CNV诊断前的得分之间差异不大,CNV诊断前平均持续时间为8.9个月。各分量表显示在总体视力、近距活动、远距活动、社会功能、角色困难、依赖和驾驶方面有统计学意义的下降。HADS和SF-36量表变化极小。

结论

基于患者对NEI-VFQ问卷的回答,对侧眼CNV的发生对视觉功能有显著影响。我们的研究被认为是第一项使用前瞻性收集的数据来证明AMD患者CNV发生所导致的与视力相关的生活质量变化的研究。

相似文献

1
Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.在对侧眼转变为新生血管性年龄相关性黄斑变性时视觉功能生活质量测量的变化。
Qual Life Res. 2017 Aug;26(8):2139-2151. doi: 10.1007/s11136-017-1547-z. Epub 2017 Mar 29.
2
Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.年龄相关性黄斑变性继发脉络膜新生血管患者在黄斑下手术随机试验入组时的健康及视力相关生活质量:SST报告第4号
Am J Ophthalmol. 2004 Jul;138(1):91-108. doi: 10.1016/j.ajo.2004.02.011.
3
Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.美国国立眼科研究所视觉功能问卷对视力变化的反应性:黄斑下脉络膜新生血管患者的研究结果——SST报告第1号
Arch Ophthalmol. 2003 Apr;121(4):531-9. doi: 10.1001/archopht.121.4.531.
4
Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5.在一项黄斑下手术随机试验入组时,眼组织胞浆菌病或特发性脉络膜新生血管患者的健康及视力相关生活质量:黄斑下手术试验报告第5号
Arch Ophthalmol. 2005 Jan;123(1):78-88. doi: 10.1001/archopht.123.1.78.
5
Vision-related quality of life in patients suffering from age-related macular degeneration.年龄相关性黄斑变性患者的视力相关生活质量
Am J Ophthalmol. 2005 Feb;139(2):271-9. doi: 10.1016/j.ajo.2004.09.028.
6
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14.年龄相关性黄斑变性出血性脉络膜新生血管病变的手术治疗:生活质量研究结果:SST报告第14号
Ophthalmology. 2004 Nov;111(11):2007-14. doi: 10.1016/j.ophtha.2004.07.024.
7
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12.年龄相关性黄斑变性中黄斑下脉络膜新生血管的手术治疗:生活质量研究结果:SST报告第12号
Ophthalmology. 2004 Nov;111(11):1981-92. doi: 10.1016/j.ophtha.2004.07.022.
8
Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.美国国立眼科研究所视觉功能问卷对进展为晚期年龄相关性黄斑变性、视力丧失和晶状体混浊的反应性:年龄相关性眼病研究报告第14号。
Arch Ophthalmol. 2005 Sep;123(9):1207-14. doi: 10.1001/archopht.123.9.1207.
9
Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration.视力下降和总体健康状况对新生血管性年龄相关性黄斑变性患者NEI-VFQ评分的相对贡献。
Arch Ophthalmol. 2004 May;122(5):758-66. doi: 10.1001/archopht.122.5.758.
10
Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.年龄相关性黄斑变性与拉丁裔人群的生活质量:洛杉矶拉丁裔眼研究。
JAMA Ophthalmol. 2016 Jun 1;134(6):683-90. doi: 10.1001/jamaophthalmol.2016.0794.

引用本文的文献

1
Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: a longitudinal clinic-based study.与年龄相关的新生血管性黄斑变性患者生活质量较差的风险因素:一项基于临床的纵向研究。
Eye (Lond). 2023 Sep;37(13):2736-2743. doi: 10.1038/s41433-023-02407-0. Epub 2023 Jan 25.
2
Assessing bidirectional associations between cognitive impairment and late age-related macular degeneration in the Age-Related Eye Disease Study 2.评估年龄相关性眼病研究 2 中认知障碍与老年相关性黄斑变性之间的双向关联。
Alzheimers Dement. 2022 Jul;18(7):1296-1305. doi: 10.1002/alz.12473. Epub 2021 Nov 10.
3
CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus.监测新生血管性年龄相关性黄斑变性对侧眼的当前概念和模式:专家小组共识。
Retina. 2020 Apr;40(4):599-611. doi: 10.1097/IAE.0000000000002768.
4
Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration.莫菲尔德 AMD 数据库报告 2:新生血管性年龄相关性黄斑变性的对侧眼受累。
Br J Ophthalmol. 2020 May;104(5):684-690. doi: 10.1136/bjophthalmol-2019-314446. Epub 2019 Oct 14.
5
Health-Related Quality of Life of Economically Disadvantaged African American Older Adults: Age and Gender Differences.经济弱势群体中的非裔美国老年人的健康相关生活质量:年龄和性别差异。
Int J Environ Res Public Health. 2019 Apr 29;16(9):1522. doi: 10.3390/ijerph16091522.
6
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular Degeneration.评价与年龄相关性黄斑变性治疗相关的临床问题和患者重要结局。
JAMA Ophthalmol. 2018 Nov 1;136(11):1217-1225. doi: 10.1001/jamaophthalmol.2018.3456.

本文引用的文献

1
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis.美国白人晚期年龄相关性黄斑变性的发病率:系统评价与荟萃分析。
Am J Ophthalmol. 2015 Jul;160(1):85-93.e3. doi: 10.1016/j.ajo.2015.04.003. Epub 2015 Apr 6.
2
Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom.在英国一个明确界定的地区,接受新生血管性年龄相关性黄斑变性治疗的患者中失明及其他程度视力损害的患病率和发病率。
Eye (Lond). 2015 Mar;29(3):403-8. doi: 10.1038/eye.2014.296. Epub 2015 Jan 16.
3
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测:系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
4
The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration.抗血管内皮生长因子治疗对年龄相关性黄斑变性新生血管患者生活质量的影响。
Ophthalmology. 2014 Jun;121(6):1246-51. doi: 10.1016/j.ophtha.2013.12.032. Epub 2014 Feb 8.
5
The prevalence of age-related eye diseases and visual impairment in aging: current estimates.与年龄相关的眼病和视力障碍在老龄化人群中的流行情况:当前估计。
Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF5-ORSF13. doi: 10.1167/iovs.13-12789.
6
Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots.未经治疗的渗出性年龄相关性黄斑变性患者的病变大小进展:使用 Lineweaver-Burk 图进行的荟萃分析。
JAMA Ophthalmol. 2013 Mar;131(3):335-40. doi: 10.1001/jamaophthalmol.2013.818.
7
The significance of early treatment of exudative age-related macular degeneration: 12 months' results.渗出型年龄相关性黄斑变性的早期治疗意义:12 个月的结果。
Wien Klin Wochenschr. 2012 Nov;124(21-22):750-5. doi: 10.1007/s00508-012-0249-3. Epub 2012 Oct 24.
8
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.抗血管内皮生长因子药物治疗新生血管性年龄相关性黄斑变性的一年视觉预后的基线预测因素。
Ophthalmology. 2013 Jan;120(1):122-9. doi: 10.1016/j.ophtha.2012.07.042. Epub 2012 Oct 6.
9
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.HORIZON:雷珠单抗治疗年龄相关性黄斑变性脉络膜新生血管的开放性扩展试验。
Ophthalmology. 2012 Jun;119(6):1175-83. doi: 10.1016/j.ophtha.2011.12.016. Epub 2012 Feb 4.
10
Time to first treatment: The significance of early treatment of exudative age-related macular degeneration.首次治疗时间:渗出性年龄相关性黄斑变性的早期治疗意义。
Retina. 2012 Jul;32(7):1260-4. doi: 10.1097/IAE.0b013e3182018df6.